Contents
pdf Download PDF pdf Download XML
87 Views
43 Downloads
Share this article
Research Article | Volume 4 Issue 3 (None, 2010) | Pages 44 - 46
Multiple eruptive periungual pyogenic granulomas during anti-CD20 monoclonal antibody therapy for rheumatoid arthritis
Under a Creative Commons license
Open Access
PMID : PMC3157817
Received
Nov. 6, 2010
Published
Dec. 19, 2010
Abstract

Background:New targeted therapies have been developed for inflammatory and neoplastic diseases.Main observation:We report on a 73-year-old woman who developed multiple eruptive periungual and subungual pyogenic granulomas. Because of severe rheumatoid arthritis the patient was treated with monoclonal anti-CD20 antibodies. Eruptive granuloma pyogenicum developed after the second antibody application and remained more than 8 weeks after targeted therapy was over. New lesions, however, did not appear.Conclusion:Eruptive granuloma pyogenicum of the nail apparatus is a possible new rare adverse effect of targeted therapies. To the best of our knowledge this is the first case in association with anti-CD20 antibody treatment.

Keywords
Recommended Articles
Case Report
Concurrent Lepra Reactions; Type 1 and Type 2 in a young male patient with borderline leprosy: Clinical and Histopathological correlation
...
Published: 02/09/2025
Original Article
Comparative Evaluation of Intralesional Corticosteroid Injection and Surgical Excision in Hypertrophic Scar Treatment
...
Published: 04/06/2022
Research Article
Efficacy of supra bioavailable itraconazole and conventional itraconazole at different dosing regimens in glabrous tinea infection
Published: 02/02/2024
Research Article
Surgical suturing-induced melanocytic nevi. A new type of eruptive melanocytic nevi?
...
Published: 30/11/2016
© Copyright Spejalisci Dermatolodzy